Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClarkson Regulatory News (CKN)

Share Price Information for Clarkson (CKN)

Share Price is delayed by 15 minutes
Get Live Data
4,636.00    52.00 (1.13%)
Bid:
4,608.00
Ask:
4,622.00
Spread: 14.00 (0.304%)
Market Cap: £1.42b
CKN Live PriceLast checked at - London Stock Exchange

Intraday Clarkson Share Chart

Director/PDMR Shareholding

6 Nov 2009 15:05

RNS Number : 1413C
Clarkson PLC
06 November 2009
Β 

ο»Ώ

NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS

This form is intended for use by anΒ issuerΒ to make aΒ RISΒ notification required byΒ DRΒ 3.1.4R(1).

Β 

(1)

AnΒ issuerΒ making a notification in respect of a transaction relating to theΒ sharesΒ or debentures of theΒ issuerΒ should completeΒ boxes 1 to 16, 23 and 24.

(2)

AnΒ issuerΒ making a notification in respect of a derivative relatingΒ toΒ theΒ sharesΒ of theΒ issuerΒ should completeΒ boxes 1 to 4, 6, 8,Β 13, 14, 16, 23 and 24.Β 

(3)

AnΒ issuerΒ making a notification in respect of options granted to aΒ director/person discharging managerial responsibilitiesΒ should completeΒ boxes 1 to 3Β and 17 to 24.Β 

(4)

AnΒ issuerΒ making a notification in respect of aΒ financial instrumentΒ relating to theΒ sharesΒ of theΒ issuerΒ (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.Β 

Β 

Please complete all relevant boxes in block capital letters.

1.Β Name of theΒ issuer

CLARKSON PLC

………………………………

2.Β State whether the notification relates toΒ 

(i) a transaction notified in accordance withΒ DTRΒ 3.1.2RΒ 

(ii) a disclosure made in accordance withΒ LR9.8.6R(1) or

(iii)Β a disclosure made in accordance with section 793 of the Companies Act (2006)

(i)

………………………………

3.Β Name ofΒ person discharging managerial responsibilities/director

ANDREW CASE

………………………………

4.Β State whether notification relates to aΒ personΒ connected with aΒ person discharging managerial responsibilities/directorΒ named in 3 and identify theΒ connected person

N/A

………………………………

5.Β Indicate whether the notification is in respect of a holding of theΒ personΒ referred to in 3 or 4 above or in respect of a non-beneficial interest

AS PER 3 ABOVE

………………………………

6.Β Description ofΒ sharesΒ (includingΒ class), debentures or derivatives or financial instruments relating toΒ shares

ORDINARY SHARES OF 25P EACH

………………………………

7.Β Name of registered shareholders(s) and, if more than one, the number ofΒ sharesΒ held by each of them

BBIHSL NOMINEES LIMITED

………………………………

8Β State the nature of the transaction

SALE

………………………………

9.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ acquired

N/A

………………………………

10.Β Percentage of issuedΒ classΒ acquired (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)

N/A

………………………………

11.Β Number ofΒ shares, debentures or financial instruments relating toΒ sharesΒ disposed

200,000

………………………………

12.Β Percentage of issuedΒ classΒ disposed (treasury sharesΒ of thatΒ classΒ should not be taken into account when calculating percentage)Β 

1.05%

………………………………

13.Β Price perΒ shareΒ or value of transaction

Β£8.00

………………………………

14.Β Date and place of transaction

ENGLANDΒ - 6 NOVEMBER 2009

………………………………

15.Β Total holding following notification and total percentage holding following notification (anyΒ treasury sharesΒ should not be taken into account when calculating percentage)

552,527Β Β SHARES

2.91%

………………………………

16.Β Date issuer informed of transaction

6 NOVEMBER 2009

………………………………

If aΒ person discharging managerial responsibilitiesΒ has been granted options by theΒ issuerΒ complete the following boxes

17Β Date of grant

N/A

………………………………

18.Β Period during which or date on which it can be exercised

N/A

………………………………

19.Β Total amount paid (if any) for grant of the option

N/A

………………………………

20.Β Description ofΒ sharesΒ or debentures involved (classΒ and number)

N/A

………………………………

………………………………

21.Β Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise

N/A

………………………………

22.Β Total number ofΒ sharesΒ or debentures over which options held following notification

N/A

………………………………

23.Β Any additional information

………………………………

24.Β Name of contact and telephone number for queries

JEFF WOYDA

020-7334-0000

………………………………

NameΒ and signatureΒ ofΒ dulyΒ authorisedΒ officerΒ ofΒ issuerΒ responsible for making notification

STEPHEN DEASEY - COMPANY SECRETARY

………………………………

Date of notification

6 NOVEMBER 2009

………………………………

ENDΒ 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSUUGCUGUPBGAQ
Date   Source Headline
1st Jun 202612:00 pmRNSTotal Voting Rights
15th May 20267:00 amRNSDirector/PDMR Shareholding
14th May 20264:30 pmRNSDirector/PDMR Shareholding
7th May 20264:45 pmRNSResult of AGM
7th May 202612:00 pmRNSTrading Statement
1st May 202612:00 pmRNSTotal Voting Rights
27th Apr 20263:00 pmRNSBlock Listing Interim Review
27th Apr 202612:00 pmRNSHolding(s) in Company
23rd Apr 20265:00 pmRNSHolding(s) in Company
21st Apr 20265:00 pmRNSDirector/PDMR Shareholding
1st Apr 20263:30 pmRNSTotal Voting Rights
30th Mar 20265:55 pmRNSAnnual Report and Notice of AGM
19th Mar 20263:00 pmRNSDirector/PDMR Shareholding
18th Mar 20261:21 pmRNSAcquisition of the Link Group
9th Mar 20267:00 amRNSPreliminary results
4th Mar 20263:30 pmRNSHolding(s) in Company
2nd Feb 202612:00 pmRNSTotal Voting Rights
9th Jan 20267:00 amRNSTrading Statement
8th Jan 202612:41 pmRNSAcquisition of Zuma Labs Limited
2nd Jan 202612:00 pmRNSTotal Voting Rights
1st Dec 202512:00 pmRNSTotal Voting Rights
3rd Nov 202512:00 pmRNSTotal Voting Rights
27th Oct 202512:00 pmRNSBlock listing Interim Review
24th Oct 20259:00 amRNSAdditional Listing
21st Oct 20253:30 pmRNSDirector/PDMR Shareholding
2nd Oct 202512:00 pmRNSCompany Secretary Change
16th Sep 20257:00 amRNSRetirement of Director
1st Sep 202511:00 amRNSTotal Voting Rights
4th Aug 20257:00 amRNSInterim results
1st Jul 202512:00 pmRNSTotal Voting Rights
2nd Jun 202511:00 amRNSTotal Voting Rights
21st May 20254:30 pmRNSDirector/PDMR Shareholding
2nd May 202511:30 amRNSDirector/PDMR Shareholding
1st May 20256:00 pmRNSResult of AGM
1st May 20253:00 pmRNSDirector/PDMR Shareholding
1st May 202512:27 pmRNSTotal Voting Rights
1st May 20257:00 amRNSTrading Statement
28th Apr 20256:00 pmRNSBlock listing Interim Review
23rd Apr 20255:30 pmRNSDirector/PDMR Shareholding
22nd Apr 20253:00 pmRNSHolding(s) in Company
15th Apr 20255:00 pmRNSDirector/PDMR Shareholding
1st Apr 20252:30 pmRNSTotal Voting Rights
25th Mar 20255:15 pmRNSAnnual Financial Report
13th Mar 20253:00 pmRNSHolding(s) in Company
12th Mar 20252:00 pmRNSDirector/PDMR Shareholding
10th Mar 20257:00 amRNSPreliminary results
3rd Feb 202512:30 pmRNSTotal Voting Rights
31st Jan 20255:00 pmRNSHolding(s) in Company
13th Jan 20254:30 pmRNSHolding(s) in Company
10th Jan 20257:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.